Literature DB >> 2380383

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B.

T J Walsh1, G P Melcher, M G Rinaldi, J Lecciones, D A McGough, P Kelly, J Lee, D Callender, M Rubin, P A Pizzo.   

Abstract

Trichosporon beigelii caused fatal disseminated infections that were resistant to amphotericin B in two granulocytopenic patients. In vitro susceptibility studies demonstrated that both index strains of T. beigelii were inhibited but not killed by amphotericin B at achievable concentrations in serum. The minimum lethal concentration for both isolates was greater than or equal to 18 micrograms/ml. Five of seven other isolates were found to have a similar pattern of amphotericin B resistance. The fact that the minimum lethal concentration of T. beigelii was many times greater than its MIC was consistent with a resistance pattern of tolerance. We concluded that T. beigelii may be resistant in vitro to amphotericin B and that this in vitro resistance was correlated with refractory, disseminated trichosporonosis in granulocytopenic patients. T. beigelii should be included in the expanding list of amphotericin B-resistant fungi.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380383      PMCID: PMC267999          DOI: 10.1128/jcm.28.7.1616-1622.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Trichosporonosis.

Authors:  T J Walsh
Journal:  Infect Dis Clin North Am       Date:  1989-03       Impact factor: 5.982

2.  Demonstration, by immunoelectronmicroscopy, of a cell wall antigen in Trichosporon beigelii that cross-reacts with Cryptococcus neoformans capsular polysaccharide.

Authors:  G P Melcher; M G Rinaldi; C L Frey; D J Drutz
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

3.  Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii.

Authors:  J D Dick; B R Rosengard; W G Merz; R K Stuart; G M Hutchins; R Saral
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

4.  Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis.

Authors:  L M Safe; S H Safe; R E Subden; D C Morris
Journal:  Can J Microbiol       Date:  1977-04       Impact factor: 2.419

5.  Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function.

Authors:  D J Drutz; R I Lehrer
Journal:  Am J Med Sci       Date:  1978 Jul-Aug       Impact factor: 2.378

6.  Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species.

Authors:  S M Seidenfeld; B H Cooper; J W Smith; J P Luby; P A Mackowiak
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

7.  Colonization and infection with Trichosporon species in the immunosuppressed host.

Authors:  H M Haupt; W G Merz; W E Beschorner; W P Vaughan; R Saral
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

8.  Amphotericin B-resistant yeast infection in severely immunocompromised patients.

Authors:  W G Powderly; G S Kobayashi; G P Herzig; G Medoff
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

9.  Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance.

Authors:  W G Merz
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

Review 10.  Emergence of a new opportunistic pathogen, Candida lusitaniae.

Authors:  R J Blinkhorn; D Adelstein; P J Spagnuolo
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

View more
  79 in total

Review 1.  Fungal resistance.

Authors:  H Bernhardt; K Zimmermann; M Knoke
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  In vitro antifungal susceptibilities of Trichosporon species.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 3.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Clinical case of endocarditis due to Trichosporon inkin and antifungal susceptibility profile of the organism.

Authors:  Jose M Ramos; Manuel Cuenca-Estrella; Felix Gutierrez; Matilde Elia; Juan L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

5.  In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts.

Authors:  Carolina Serena; Francisco Javier Pastor; Montserrat Ortoneda; Javier Capilla; Nicole Nolard; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

Review 6.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

Review 7.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.

Authors:  E J Anaissie; R Hachem; N C Karyotakis; A Gokaslan; M C Dignani; L C Stephens; C K Tin-U
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

9.  PCR detection of DNA specific for Trichosporon species in serum of patients with disseminated trichosporonosis.

Authors:  H Nagai; Y Yamakami; A Hashimoto; I Tokimatsu; M Nasu
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 10.  Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.

Authors:  Prit Lakhani; Akash Patil; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2018-11-08       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.